Bio-Techne (TECH) Accumulated Depreciation & Amortization (2010 - 2026)

Bio-Techne's Accumulated Depreciation & Amortization history runs 17 years deep, the most recent figure standing at $300.8 million for Q1 2026.

• In Q1 2026, Accumulated Depreciation & Amortization rose 7.9% year-over-year to $300.8 million; the TTM figure through Mar 2026 stood at $300.8 million (up 7.9% YoY), while the FY2025 annual figure was $286.1 million, up 11.53% from the prior year.
• Accumulated Depreciation & Amortization was $300.8 million for Q1 2026 at Bio-Techne, up from $293.1 million in the prior quarter.
• In the past five years, Accumulated Depreciation & Amortization ranged from a high of $300.8 million in Q1 2026 to a low of $206.8 million in Q1 2022.
• Historically, Accumulated Depreciation & Amortization has averaged $252.9 million across 5 years, with a median of $251.9 million in 2024.
• The sharpest annual moves came in 2023 and 2026: Accumulated Depreciation & Amortization advanced 11.59% in 2023, then grew 7.9% in 2026.
• A 5-year view of Accumulated Depreciation & Amortization shows it stood at $223.3 million in 2022, then climbed by 9.79% to $245.2 million in 2023, then rose by 10.24% to $270.3 million in 2024, then advanced by 8.43% to $293.1 million in 2025, then increased by 2.63% to $300.8 million in 2026.
• The last three Accumulated Depreciation & Amortization figures came in at $300.8 million (Q1 2026), $293.1 million (Q4 2025), and $289.0 million (Q3 2025), per Business Quant data.